Cargando…
Metabolite Profiling of Clozapine in Patients Switching Versus Maintaining Treatment: A Retrospective Pilot Study
PURPOSE/BACKGROUND: Pharmacokinetics may be of relevance for the risk of clozapine discontinuation. We compared metabolite profiles, accounting for smoking habits, in patients switching versus maintaining clozapine treatment at therapeutic concentrations. METHODS/PROCEDURES: Adult patients with cloz...
Autores principales: | Kyllesø, Lennart, Smith, Robert Løvsletten, Wollmann, Birgit M., Karlstad, Øystein, Andreassen, Ole A., Molden, Espen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426748/ https://www.ncbi.nlm.nih.gov/pubmed/35916581 http://dx.doi.org/10.1097/JCP.0000000000001585 |
Ejemplares similares
-
Absolute and Dose-Adjusted Serum Concentrations of Clozapine in Patients Switching vs. Maintaining Treatment: An Observational Study of 1979 Patients
por: Kyllesø, Lennart, et al.
Publicado: (2021) -
Undetectable or subtherapeutic serum levels of antipsychotic drugs preceding switch to clozapine
por: Kyllesø, Lennart, et al.
Publicado: (2020) -
Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients—a genome-wide association study adjusting for smoking habits
por: Smith, Robert Løvsletten, et al.
Publicado: (2020) -
Correction: Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients—a genome-wide association study adjusting for smoking habits
por: Smith, Robert Løvsletten, et al.
Publicado: (2020) -
Impact of NFIB and CYP1A variants on clozapine serum concentration—A retrospective naturalistic cohort study on 526 patients with known smoking habits
por: Lenk, Hasan Çağın, et al.
Publicado: (2022)